After a year of controversy and complaints, Sen. Elizabeth Warren is asking a federal watchdog to investigate GSK over its ...
The biggest vaccine brand it has acquired in the deal is Bexsero, a new vaccine to prevent meningitis B, with a further candidate vaccine in late-stage development, MenABCWY. GSK intends to report ...
With Sunday’s Academy Awards ceremony in the rearview mirror, GSK is looking ahead to a potential blockbuster premiere of its ...
For GSK CEO Emma Walmsley, there was good news and bad news in the company’s annual report. | For GSK CEO Emma Walmsley, ...
Hosted on MSN24d
GSK's antibiotic drug Augmentin is India's highest-selling brand with Rs 80 crore monthly saleOver 3,100 new brands were introduced during the year, collectively registering sales of Rs 1,097 crore, according to data from IQVIA. The largest number of new brands launched in 2024 were in the ...
ICER's report also analyzed cost-effectiveness, framing pricing calculations based on comparator therapies, including ...
Discover GSK's impressive stock surge, boosted by strong earnings, a share buyback program, and a focus on specialty medicines.
NEW YORK, March 10, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in GSK plc ("GSK" or the "Company") (NYSE: GSK) of a class action securities lawsuit. CLASS DEFINITION ...
LOS ANGELES, March 11, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against GSK plc.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results